PMV Pharmaceuticals, Inc.
$1.43
▲
0.75%
2026-04-21 08:54:00
www.pmvpharma.com
NMS: PMVP
Explore PMV Pharmaceuticals, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$73.59 M
Current Price
$1.43
52W High / Low
$1.88 / $0.81
Stock P/E
—
Book Value
$1.96
Dividend Yield
—
ROCE
-81.99%
ROE
-55.37%
Face Value
—
EPS
$-1.48
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
54
Beta
1.4
Debt / Equity
0.8
Current Ratio
10.09
Quick Ratio
10.09
Forward P/E
-1.2
Price / Sales
—
Enterprise Value
$-41.71 M
EV / EBITDA
0.48
EV / Revenue
—
Rating
None
Target Price
$7.75
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Dyne Therapeutics, Inc. | $20.02 | — | $3.37 B | — | -41.2% | -55.71% | $25 / $7.38 | $5.89 |
| 2. | GeoVax Labs, Inc. | $1.17 | — | $3.38 M | — | -498.05% | -3.77% | $34.75 / $1.14 | $4.13 |
| 3. | CalciMedica, Inc. | $0.66 | — | $9.49 M | — | -235.71% | -7.61% | $7.2 / $0.46 | $-0.43 |
| 4. | Silo Pharma, Inc. | $0.67 | — | $8.38 M | — | -61.55% | -74.57% | $1.19 / $0.22 | $0.47 |
| 5. | Shattuck Labs, Inc. | $7.88 | — | $538.88 M | — | -61.34% | -60.25% | $7.68 / $0.71 | $1.3 |
| 6. | MetaVia Inc. | $1.51 | — | $7.13 M | — | -250.37% | -1.96% | $19.03 / $1.17 | $2.31 |
| 7. | Outlook Therapeutics, Inc. | $0.37 | — | $38.71 M | — | 246.27% | 118.61% | $3.39 / $0.16 | $-0.6 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -19.24 M | -22.52 M | -22.88 M | -21.56 M | -25.17 M | — |
| Net Profit | -18.04 M | -21.06 M | -21.21 M | -17.44 M | -23 M | — |
| EPS in Rs | -0.34 | -0.39 | -0.4 | -0.33 | -0.43 | -0.37 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -86.21 M | -85.45 M | -80.13 M | -77.04 M |
| Net Profit | -77.74 M | -58.71 M | -68.96 M | -73.32 M |
| EPS in Rs | -1.46 | -1.1 | -1.29 | -1.37 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 116.56 M | 191.29 M | 252.15 M | 270.31 M |
| Total Liabilities | 11.85 M | 15.21 M | 26.46 M | 24.28 M |
| Equity | 104.71 M | 176.08 M | 225.69 M | 246.03 M |
| Current Assets | 115.23 M | 175.66 M | 207.41 M | 247.01 M |
| Current Liabilities | 11.41 M | 14.37 M | 14.03 M | 10.83 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -73.58 M | -51.28 M | -55.66 M | -63.76 M |
| Investing CF | 70.17 M | 53.35 M | -50.55 M | -1.37 M |
| Financing CF | 0.51 M | 0.31 M | 35.58 M | 0.96 M |
| Free CF | -73.61 M | -51.94 M | -56.62 M | -71.74 M |
| Capex | -0.03 M | -0.66 M | -0.96 M | -7.98 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 14.87% | 5.94% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.